Microbiota as a potentially-modifiable factor influencing COVID-19

Area of Science:

• Microbiology
• Virology
• Immunology

Background:

• Respiratory viral infections, including SARS-CoV-2, exhibit significant heterogeneity in outcomes.
• Environmental factors, beyond host genetics, likely influence infection susceptibility and disease severity.
• The role of the host's microbiome in modulating responses to respiratory viruses is an emerging area of research.

Purpose of the Study:

• To explore the hypothesis that the host microbiome composition influences susceptibility and severity of respiratory viral infections.
• To review existing evidence supporting the microbiome's role in viral pathogenesis.
• To discuss potential strategies for microbiome manipulation to mitigate viral disease.

Main Methods:

• Literature review and synthesis of current research on the microbiome and respiratory viral infections.
• Analysis of epidemiological and clinical data related to host factors and viral outcomes.
• Speculative discussion on therapeutic interventions targeting the microbiome.

Main Results:

• The microbiome is increasingly recognized as a critical factor in host-pathogen interactions.
• Evidence suggests a link between specific microbial community compositions and differential responses to viral exposures.
• The microbiome may impact innate and adaptive immune responses relevant to viral clearance and inflammation.

Conclusions:

• The host microbiome represents a significant, modifiable factor influencing respiratory viral infection outcomes.
• Targeting the microbiome offers a promising avenue for novel therapeutic and preventative strategies against respiratory viruses like SARS-CoV-2.
• Further research is needed to elucidate specific microbial mechanisms and develop effective microbiome-based interventions.